IperionX reports quarterly results, shares rise
IperionX Limited, a company specializing in miscellaneous metal ores, today reported its quarterly results in a filing with ...
Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis
Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final ...
Zacks.com on MSN1d
Merck Halts Second PAH Drug Study Early on Strong Efficacy Results
MRK's decision to stop the late-stage HYPERION study on PAH drug Winrevair ahead of time comes after evaluating the drug's ...
GlobalData on MSN2d
MSD halts Winrevair trial due to success of previous study
MSD said that its sotatercept steering committee called for the trial to end as patients are moved to the ongoing open-label ...
digitalmarketreports4d
Hyperion Functional Medicine: Transforming Cancer Care with Functional Oncology
Hyperion Functional Medicine introduces a transformative approach to cancer care through its Functional Oncology program, designed to optimize treatment, ...